Viewing Study NCT00002956


Ignite Creation Date: 2025-12-24 @ 11:30 PM
Ignite Modification Date: 2026-01-26 @ 6:35 PM
Study NCT ID: NCT00002956
Status: WITHDRAWN
Last Update Posted: 2016-03-21
First Post: 1999-11-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Immunotherapy for Lymphoproliferative Diseases Associated With Epstein-Barr Virus in Patients Who Have Undergone Organ Transplants
Sponsor: University of Alabama at Birmingham
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent adult Hodgkin lymphoma View
None recurrent childhood lymphoblastic lymphoma View
None childhood diffuse large cell lymphoma View
None childhood immunoblastic large cell lymphoma View
None recurrent/refractory childhood Hodgkin lymphoma View
None T-cell large granular lymphocyte leukemia View
None recurrent grade 1 follicular lymphoma View
None recurrent grade 2 follicular lymphoma View
None recurrent grade 3 follicular lymphoma View
None recurrent adult diffuse small cleaved cell lymphoma View
None recurrent adult diffuse mixed cell lymphoma View
None recurrent adult diffuse large cell lymphoma View
None recurrent adult immunoblastic large cell lymphoma View
None recurrent adult lymphoblastic lymphoma View
None recurrent adult Burkitt lymphoma View
None recurrent childhood small noncleaved cell lymphoma View
None recurrent childhood large cell lymphoma View
None recurrent mantle cell lymphoma View
None recurrent marginal zone lymphoma View
None recurrent small lymphocytic lymphoma View
None extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue View
None nodal marginal zone B-cell lymphoma View
None splenic marginal zone lymphoma View